Primary prophylaxis with tacrolimus in kidney transplants in China

Transplantation Proceedings

Volumn 30, Issue 7, 1998, Pages 3590-3591

  Cheng, H M ^a   Wong, F K M ^a   Choi, K S ^a   Cheng, Y L ^a   Chak, W L ^a   Chan, Y H ^a   Chau, K F ^a   Li, C S ^a  

^a QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; HEPATITIS B SURFACE ANTIGEN; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; TACROLIMUS;

ADULT; ARTICLE; BLOOD; CHINA; CLINICAL TRIAL; CYTOMEGALIC INCLUSION BODY DISEASE; FEMALE; FOLLOW UP; GRAFT REJECTION; HISTOCOMPATIBILITY TEST; HUMAN; IMMUNOLOGY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; TIME;

ADULT; ANTILYMPHOCYTE SERUM; AZATHIOPRINE; CHINA; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HEPATITIS B SURFACE ANTIGENS; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; TACROLIMUS; TIME FACTORS;

EID: 0032209789     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)01149-X     Document Type: Article

References (7)

1. Schreiber SL, Crabtree GR: Immunol Today 13(4):136, 1992
2. Japanese FK506 Study Group: Transplant Proc 27:829, 1995
3. Shapiro R, Jordan ML, et al: Transplantation 59:485, 1995
4. Pirsch JD, Miller, J et al: Transplantation 63(7):977, 1997
5. Mayer AD, Dmitrewski J, et al: Transplantation 64(3):436, 1997
6. Kerchner RP, Fitzsimmons WE, et al: Transplantation (62): 920, 1996
7. Hibberd PK, Tolkoff-Rubin NE, et al: Ann Intern Med 123(1):18, 1995